Last reviewed · How we verify

NCT05073978

B-vitamin Levels and Adverse Pregnancy Outcomes

Completed Last updated 1 June 2023
What this trial tests

trial testing No intervention in Birth Defect in 7,500 participants. Completed in 31 December 2022.

Timeline
1 December 2020
Primary endpoint
31 December 2022
31 December 2022

Quick facts

Lead sponsorWestlake University
StatusCompleted
Study typeOBSERVATIONAL
Enrollment7,500
Start date1 December 2020
Primary completion31 December 2022
Estimated completion31 December 2022
Sites1 location across China

Drugs / interventions tested

Conditions studied

Sponsor

Westlake University

Who can join

Adults 18 to 45, female only, with Birth Defect or Pregnancy Loss. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

This prospective nested case-control study aims to examine the effects of blood vitamin B levels in first-trimester pregnant women on the pregnancy outcomes

Publications & conference data

No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.

Verify or expand the search:

Other trials of No intervention

Trials testing the same drug.

Other recruiting trials for Birth Defect

Currently open trials in the same condition.

Other Westlake University trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT05073978.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing